BioProcess International is part of the Informa Connect Division of Informa PLC

Informa PLC|ABOUT US|INVESTOR RELATIONS|TALENT

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

About Subscribe Contribute

Upstream

Recent in Manufacturing

See all

thumbnail

Information Technology

Artificial Intelligence in the Biopharmaceutical Industry: Treacherous or Transformative?Artificial Intelligence in the Biopharmaceutical Industry: Treacherous or Transformative?

byToni Manzano, William Whitford

May 10, 2024

Monoclonal Antibody Productivity

Single Use

A Fully Single-Use Downstream Process for Monoclonal Antibodies A Fully Single-Use Downstream Process for Monoclonal Antibodies

byShunsuke Shiina, Neha Saxenaand 1 more

Apr 17, 2024

Analytical

Recent in Analytical

See all

thumbnail

Process Development

Scaling To Meet Demand Across the Life Cycle of a Recombinant Protein Scaling To Meet Demand Across the Life Cycle of a Recombinant Protein

byPramthesh Patel

May 15, 2024

Stable Cell-Line Transfection

Cell Line Development

A Strategy for Sequence-Variant Control Leveraging Next-Generation Sequencing of Plasmid DNA Used for Stable Cell-Line Transfection A Strategy for Sequence-Variant Control Leveraging Next-Generation Sequencing of Plasmid DNA Used for Stable Cell-Line Transfection

byShuai Wang, Dujuan Lianand 7 more

May 14, 2024

Business

Recent in Business

See all

business man in choppy waters

Economics

Navigating Choppy Waters: Three Resilient Marketing Tactics for Biotechnology Companies amid Market Turmoil Navigating Choppy Waters: Three Resilient Marketing Tactics for Biotechnology Companies amid Market Turmoil

byDaniel Lofaso

May 10, 2024

Therapeutic Modalities

Recent in Therapeutic Modalities

See all

thumbnail

Cell Therapies

Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 1 — In-Process and Drug Product Control Analytical Considerations for Gene-Modified Hematopoietic Stem and Progenitor Cell Therapies: Part 1 — In-Process and Drug Product Control

byBrent Morse, Alicja Fiedorowicz

May 10, 2024

thumbnail

Gene Therapies

Bringing Your Cell and Gene Therapy Offerings to Market Bringing Your Cell and Gene Therapy Offerings to Market

byStan Bonn

May 7, 2024

BioProcess Insider

Recent in BioProcess Insider

See all

thumbnail

Deal Making

J&J expands immunotherapy portfolio with $850m Proteologix buy J&J expands immunotherapy portfolio with $850m Proteologix buy

byShreeyashi Ojha

May 17, 2024

2 Min Read

thumbnail

Facilities & Capacity

Bolt Bio cuts workforce by 50% to refocus pipeline Bolt Bio cuts workforce by 50% to refocus pipeline

byMillie Nelson

May 17, 2024

2 Min Read

Global Markets
Bioprocess Insider

BIO 2019: Biotech's always sunny in Philadelphia

BPI Staff

June 5, 2019

1 Min Read

BIO 2019: Biotech's always sunny in Philadelphia

Good weather, good conference and good news across all elements of biopharma as industry flocks to Philadelphia for BIO 2019. We have mined the Twittersphere to bring you a selection of what you may have missed.